ImmunityBio, Inc.
IBRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001326110
In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 2 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding ImmunityBio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 166 | 2 | 194 | +30 |
| Shares | 66.4M | 1.64M | 61.9M | −2.90M (−4.5%) |
| Value | $356.9M | $8.78M | $391.1M | +$42.9M (+12.3%) |
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (51)
Institutions that held ImmunityBio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (21)
Institutions that held ImmunityBio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Perceptive Advisors LLC | 1,052,887 | $5.65M |
| D. E. Shaw & Co., Inc. | 236,634 | $1.27M |
| American International Group, Inc. | 65,341 | $350.9K |
| Cubist Systematic Strategies, LLC | 56,968 | $305.9K |
| Dark Forest Capital Management LP | 45,433 | $244.0K |
| Creative Planning | 40,438 | $217.2K |
| Panagora Asset Management Inc | 27,279 | $146.5K |
| GTS Securities LLC | 20,467 | $109.9K |
| Brookstone Capital Management | 18,715 | $100.5K |
| Axxcess Wealth Management, LLC | 15,800 | $84.8K |
| SEI Investments Co | 13,772 | $74.0K |
| Wolverine Trading, LLC | 13,303 | $71.4K |
| Virtu Financial LLC | 11,285 | $61.0K |
| HighTower Advisors, LLC | 10,302 | $55.0K |
| Eqis Capital Management, Inc. | 10,023 | $53.8K |
| Metropolitan Life Insurance Co | 6,038 | $32.4K |
| Quent Capital, LLC | 1,824 | $9.79K |
| Federated Hermes, Inc. | 198 | $1.06K |
| Sofos Investments, Inc. | 52 | $287 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 26 | $139 |
| Investors Research Corp | 15 | $81 |
Not filed for Q2 2024 yet (2)
Institutions that held ImmunityBio, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 1,548,826 | $8.32M |
| Winning Points Advisors, LLC | 92,786 | $465.8K |